Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for Cognitive Impairment in Pediatric Brain Tumor Survivors
NCT06051240Phase 2Recruiting
- Sponsor
- Region Stockholm
- Start
- Feb 2024
- Primary completion
- Aug 2030
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cognitive impairment comparing Lithium with Placebo (2 arms). Primary endpoint: Processing Speed Index at 2 years. Started Feb 2024; status: recruiting.
02
Drugs
lithium
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT06051240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06051240.